Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

Lataukset:

Hauser, Stephen L.

Bar-Or, Amit

Comi, Giancarlo

Giovannoni, Gavin

Hartung, Hans-Peter

Hemmer, Bernhard

Lublin, Fred

Montalban, Xavier

Rammohan, Kottil W.

Selmaj, Krzysztof

Traboulsee, Anthony

Wolinsky, Jerry S.

Arnold, Douglas L.

Klingelschmitt, Gaelle

Masterman, Donna

Fontoura, Paulo

Belachew, Shibeshih

Chin, Peter

Mairon, Nicole

Garren, Hideki

Kappos, Ludwig

Elovaara, Irina

for the OPERA I and OPERA II Clinical Investigators

2017

New England Journal of Medicine 376 3
221-234
Lääketieteen ja biotieteiden tiedekunta - Faculty of Medicine and Life Sciences

This publication is copyrighted. You may download, display and print it for Your own personal use. Commercial use is prohibited.